|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.34 SEK | +0.21% |
|
-2.42% | -14.42% |
| 06-23 | Citadel Back as Public Short Seller in Synact Pharma | FW |
| 06-18 | Edison Maintains Its Valuation for Synact Pharma After Trial Results | FW |
| Market Cap | 1.03B 106M 92.73M 85.61M 79.11M 150M 10.12B 153M 400M 4.95B 397M 388M 17.2B | P/E 2026 * |
-13x | P/E 2027 * | -25.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.01B 104M 91.15M 84.15M 77.77M 147M 9.95B 150M 393M 4.87B 390M 382M 16.9B | EV / Sales 2026 * |
7.29x | EV / Sales 2027 * | 49.8x |
| Free-Float |
70.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: SynAct Pharma AB
| 1 day | -0.88% | ||
| 1 week | -2.42% | ||
| Current month | -8.12% | ||
| 1 month | +41.17% | ||
| 3 months | +6.73% | ||
| 6 months | -11.28% | ||
| Current year | -14.42% |
| 1 week | 17.9 |  | 20 |
| 1 month | 7.05 | | 22.25 |
| Current year | 7.05 | | 24.4 |
| 1 year | 7.05 | | 25.3 |
| 3 years | 4.98 | | 124.6 |
| 5 years | 4.98 | | 146 |
| 10 years | 4.75 | | 146 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
CEO | Chief Executive Officer | 64 | 31/12/2013 |
Ann Kristin Led
DFI | Director of Finance/CFO | - | 28/02/2026 |
Kirsten Harting
CTO | Chief Tech/Sci/R&D Officer | - | 14/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
BRD | Director/Board Member | 64 | 19/03/2024 |
Anders Kronborg
CHM | Chairman | 62 | 19/03/2024 |
Sten Scheibye
BRD | Director/Board Member | 74 | 19/03/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-09 | Buy | Chairman | 2,750 | 0.0052% | ||
| 03-08 | Buy | Executive/Senior Manager | 1,500 | 0.0028% | ||
| 03-08 | Quantass ApS
| Buy | Company | 7,900 | 0.0148% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -2.42% | -3.78% | -73.90% | 106M | |
| -1.60% | +1.94% | +56.22% | +168.08% | 1,102B | |
| -1.40% | +3.92% | +69.42% | +65.47% | 643B | |
| -1.04% | +0.70% | +33.23% | +87.99% | 450B | |
| -1.35% | +1.86% | +29.96% | +26.26% | 336B | |
| -0.71% | +0.72% | +28.85% | +46.77% | 288B | |
| -1.31% | -0.26% | -28.18% | -39.13% | 222B | |
| -0.81% | +1.72% | +23.75% | +63.55% | 199B | |
| -4.04% | +7.45% | +21.87% | +78.82% | 169B | |
| +0.31% | +1.07% | -5.80% | -32.36% | 137B | |
| Average | -0.90% | +1.20% | +22.55% | +39.16% | 354.52B | |
| Weighted average by Cap. | -1.20% | +2.07% | +39.85% | +85.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 139M 14.25M 12.5M 11.54M 10.67M 20.22M 1.36B 20.62M 53.91M 668M 53.53M 52.35M 2.32B | 21.15M 2.17M 1.91M 1.76M 1.63M 3.08M 208M 3.14M 8.22M 102M 8.16M 7.98M 353M |
| Net income | 52.18M 5.36M 4.7M 4.34M 4.01M 7.6M 513M 7.75M 20.27M 251M 20.13M 19.69M 872M | -26.04M -2.68M -2.35M -2.17M -2M -3.79M -256M -3.87M -10.12M -125M -10.05M -9.83M -435M |
| Net Debt | -17.48M -1.8M -1.57M -1.45M -1.34M -2.55M -172M -2.6M -6.79M -84.14M -6.74M -6.6M -292M | 24.86M 2.55M 2.24M 2.07M 1.91M 3.62M 245M 3.69M 9.66M 120M 9.59M 9.38M 415M |
Employees
8
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/07/26 | SEK 19.34 | +0.21% | 345,402 |
| 07/07/26 | SEK 19.30 | +0.42% | 366,957 |
| 06/07/26 | SEK 19.22 | +1.59% | 211,207 |
| 03/07/26 | SEK 18.92 | +2.16% | 202,458 |
| 02/07/26 | SEK 18.52 | -6.56% | 328,846 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SYNACT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
